» Articles » PMID: 19803715

Distribution of Four HIV Type 1-resistance Polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini Population

Overview
Publisher Mary Ann Liebert
Date 2009 Oct 7
PMID 19803715
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Allelic differences of chemokine (C-C motif ) receptor 5 (CCR5) and CCR2, as well as the ligand for the chemokine receptor CXCR4, stromal-derived factor (SDF-1), are known to suppress HIV-1 transmission and to be involved in delay in HIV-1 disease progression. The aim of our study was to investigate the frequencies of four mutations that confer resistance to HIV-1: CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A among Bahrainis. We have studied the DNA polymorphisms in 304 unrelated healthy Bahraini individuals without any known history of HIV-1 infection or AIDS symptoms. The CCR5-Delta32 mutation was detected by PCR analysis, while the CCR5-m303, CCR2-64I, and SDF1-3'A mutations were detected by PCR-restriction fragment length polymorphism (PCR-RFLP) tests. Allele frequencies and the fit to the Hardy-Weinberg equilibrium were evaluated using the Arlequin population genetics application. The frequencies of the CCR5-Delta32, CCR2-64I, and SDF1-3'A alleles were 2.8%, 8.9%, and 26.5%, respectively. No mutant alleles were detected for the CCR5-m303 mutation in 304 individuals. We estimated the risk of AIDS onset (relative hazard), computed from the three-locus genotype data. This is the first report of these four mutations conferring resistance to HIV-1 in the Bahraini population. The presence of the CCR5-Delta32 allele among Bahrainis may be attributed to the admixture with people of European descent. The CCR2-64I allele and especially the SDF1-3'A allele are predominant in the Bahraini population and may be associated with resistance to fast HIV-1 infection in Bahrainis, and thus their genotyping can be used for prognosis in HIV-infected individuals.

Citing Articles

Variability of the rs333 in Polish patients with lupus erythematosus.

Mlicka D, Duleba A, Czajkowski R, Gawrych M, Wozniacka A, Robak E Postepy Dermatol Alergol. 2021; 38(2):131-136.

PMID: 34408579 PMC: 8362790. DOI: 10.5114/ada.2021.104288.


Identification of Variants of Hepatitis C Virus (HCV) Entry Factors in Patients Highly Exposed to HCV but Remaining Uninfected: An ANRS Case-Control Study.

Fouquet B, Ghosn J, Quertainmont Y, Salmon D, Rioux C, Duvivier C PLoS One. 2015; 10(11):e0142698.

PMID: 26571379 PMC: 4646460. DOI: 10.1371/journal.pone.0142698.


Low prevalence of CCR5-Δ32, CCR2-64I and SDF1-3'A alleles in the Baiga and Gond tribes of Central India.

Bharti D, Kumar A, Mahla R, Kumar S, Ingle H, Yadav T Springerplus. 2015; 4:451.

PMID: 26322257 PMC: 4547972. DOI: 10.1186/s40064-015-1238-6.


Distribution of the mutated delta 32 allele of CCR5 co-receptor gene in Iranian population.

Rahimi H, Farajollahi M, Hosseini A Med J Islam Repub Iran. 2015; 28:140.

PMID: 25694998 PMC: 4322332.


Genetics of Sub-Saharan African Human Population: Implications for HIV/AIDS, Tuberculosis, and Malaria.

Mboowa G Int J Evol Biol. 2014; 2014:108291.

PMID: 25202468 PMC: 4151494. DOI: 10.1155/2014/108291.